comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 17:03:37 - browse：7136

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Methadone treatment changes are coming. Do they go far enough?

WSS

PEPFAR is under serious threat — and so is global health

Telehealth for opioid use disorder is lifesaving

App could help diagnose ear infections more accurately — and at home

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Food makers tried to stack nutrition panel with preferred experts

Wikipedia

comprehensive

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Will the IRA bring competition to the biologics market?

How to save PrEP access — and even expand it

Acelyrin, a rare IPO success, stumbles in its first big test

Wildfire smoke exposes gaps in outdoor worker protections

SCOTUS questions limit to govt efforts to fight misinformation

Affirmative action in medical school literally saved lives

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Virginia high school admissions case could be legal follow

White House touts steps to stem shortages of cancer treatments

Wikipedia

Future doctors should be trained to promote social change

Readout Newsletter: Bluebird, CVS, Contineum

WATCH: Why do bright lights make us see spots?

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Food makers tried to stack nutrition panel with preferred experts

How housing is health care on Long Island

hotspot

Wikipedia

hotspot

focus